Navigation Links
PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
Date:10/5/2009

torical facts, including statements proceeded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) under the DHHS Request for Proposals for an Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC").

Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.

SOURCE PharmAthene, Inc.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
2. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
3. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
4. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
5. PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
6. PharmAthenes 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review
7. PharmAthene Reports First Quarter 2009 Financial and Operational Results
8. PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
9. PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
10. PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
11. PharmAthene Announces $5.5 Million Public Equity Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... emission abatement projects in North America . ... a municipality in the Southern USA ... failed to meet the customer,s requirements. This demonstrates the value our ... Webb , President and Chief Executive Officer.  ...
(Date:8/31/2015)... , Aug. 31, 2015 Research and Markets ... "Israel Biomedical Sensors Market - Growth, Trends & ... The Israel Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:8/31/2015)... , Aug. 31, 2015  US-Australian drug discovery ... ) today confirmed its comprehensive scientific review has ... platforms in areas of unmet patient need. Novogen ... remaining preclinical projects prior to entering into Phase ... Acting Chief Executive Officer, Iain ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... ... (PGIs), as a high priority in the drug development approval process. Thus, innovator ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple ...
Breaking Biology Technology:Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3
... The ACHDC ... and is today the largest of its kind in California. Today, the ACHDC has ... ... has announced that total contributions now exceed $2 million over the ten-year lifetime of the ...
... 9 Quest Diagnostics Incorporated (NYSE: DGX ), ... today announced that its Board of Directors declared a quarterly ... 2010, to shareholders of record of Quest Diagnostics common stock ... , Quest Diagnostics is the world,s leading provider of diagnostic ...
... VANCOUVER, Dec. 8 /PRNewswire/ - Sirius Genomics, a developer of ... President and Chief Executive Officer, replacing Dr. Brad Popovich. , ... President and CEO over the last four years. Brad has ... a very short period of time. Brad has also managed ...
Cached Biology Technology:Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Sirius Genomics Announces Change in Leadership 2
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Saudi Arabia Biomedical Sensors Market - ... offering. The Saudi Arabia Biomedical Sensors ... a CAGR of 3.64% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/25/2015)... CITY and BELLEVUE, Wash. ... leader in advanced robotic systems, announced today it will ... unmanned ground vehicle (UGV), at the National Tactical Officers ... The Guardian S is the first-ever ... culmination of years of research and in-field trials and ...
(Date:8/20/2015)... 20, 2015 The wearable technology market ... active and healthy. However, wearable technology has the ... to help improve diagnostic capabilities and therapeutic outcomes. ... Wearable Technologies Conference 2015 , where ... wearables in healthcare.    "Over the ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... married has often been associated with improving people,s health, but ... alters hormones in a way that reduces stress. Unmarried ... responses to stress as do married people, said Dario Maestripieri, ... and lead author of the study, published in the current ...
... in preventing fouling of ship bottoms. Researchers at the University ... barnacle to react to the substance, opening up the possibility ... and on the environment. Fouling of hulls is a ... well as large cargo ships. The University of Gothenburg has ...
... Society today released initial field observations that indicate that ... waters has resulted in a large-scale bleaching event that ... "Rapid Response Unit" of marine biologists was dispatched to ... of Indonesialocated on the northern tip of the island ...
Cached Biology News:Marriage and committed romance reduce stress-related hormone production 2Gene that causes barnacles to avoid ship hulls identified 2Massive coral mortality following bleaching in Indonesia 2Massive coral mortality following bleaching in Indonesia 3
... a hydrolytic enzyme that catalyzes the ... glucose, maltose, maltotriose and,dextrins. The level ... the human,body are of clinical importance,1-3 ... enzymes for industry.4, The EnzChek Amylase ...
... new Class II safety cabinets Heraeus HERAsafe KS ... user-orientated design. ,The new frameless slanted window ... area. The new front window design makes it ... large work aperture with a height of more ...
... a high-quality four-place microplate shaker with variable ... is adjustable from 100 to 1350 cycles/minute. ... small orbit ensure effective shaking for microplate ... and easy to set for 0 to ...
... orbital shaker stands both present ... ergonomic height, and help protect ... welded tubular steel, these heavy-duty ... the weight and minimize the ...
Biology Products: